LDE225
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for LDE225, covering 2015-04-27 to 2026-02-09. Get the full timeline:
Most recent: Clinical Trial Update: Phase IB Trial of LDE225 and Paclitaxel in Recurrent Ovarian Cancer [Phase 1]